ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
- Авторлар: Tabeeva GR1, Azimova Y.E1, Tabeeva G1, Azimova Y1
-
Мекемелер:
- Шығарылым: № 7 (2010)
- Беттер: 48-52
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278377
- ID: 278377
Дәйексөз келтіру
Толық мәтін
Аннотация
One of the most common complications of diabetes mellitus (DM) is a polyneuropathy (PNP). The article presents statistical data, classification of diabetic neuropathy, diagnostic criteria, pathogenesis and principles of treatment of this complication of DM. The blood glucose level control and metabolic therapy with α-lipoic (thioctic) acid are major pathogenetic-based methods of treatment of DM. Thiogamma is effective, safe and easy to use form of α-lipoic acid, which can be administered for the treatment of different categories of patients with DM, including children, and patients with different forms of diabetic PNP.
Негізгі сөздер
Әдебиет тізімі
- Афонина Ж.А., Строков И.А., Аметов А.С. и др. Лечение тоннельных невропатий рук у больных сахарным диабетом // РМЖ. 2008. № 12. C. 3-7.
- Бегма А.Н., Бегма И.В. Комплексное лечение язвенных дефектов у больных с синдромом диабетической стопы // Фарматека. 2004. № 19/20. C. 88-90.
- Сивоус Г.И. Антиоксидантная терапия диабетической периферической полиневропатии у детей и подростков с использованием α-липоевой кислоты. // Фарматека. 2004. № 9/10. C. 55-59.
- Шилов А.М., Мельник М.В. Применение препаратов с метаболическим действием в комплексном лечении осложнений сахарного диабета (ангио- и полинейропатии) // Фарматека. 2006. № 5. С. 1-6.
- Dyck PJ, Melton LJ 3rd, O'Brien PC, et al. Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes 1997;46(Suppl. 2):5-8.
- Fedele D, Coscelli C, Cucinotta D. Management of erectile dysfunction in diabetic subjects: results from a survey of 400 diabetes centres in Italy. Diabetes Nutr Metab 2001;14(5):277-82.
- Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl). Diabete Metab 1977;3(4):245-56.
- Reed LJ, De Buck BG, et al. Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 1951;114:93-4.
- Sachse G, Willms B. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Horm Metab Res 1980;9(Suppl.):105-7.
- Sands ML, Shetterly SM, Franklin GM, et al. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1997;20(3):322-9.
Қосымша файлдар
